Job Recruitment Website - Recruitment portal - Does anyone know Professor He Chuan from Ebion Company?

Does anyone know Professor He Chuan from Ebion Company?

Professor He Chuan is a tenured professor in the Department of Chemistry of the University of Chicago, and a John T. Wilson Chair Professor. He has won many awards, such as American Young Scientist Award for Cancer Research and Keck Foundation Award for Outstanding Young Scholars in Medical Research, and was selected as a researcher at Howard Hughes Medical College (HHMI)20 13. After years of development, HHMI has become one of the largest private foundations for biomedical research in the United States, and has long been committed to supporting cutting-edge basic research in the biomedical field, which plays a decisive role in the development of biomedical research in the United States or the world. Every year, the institute selects some of the most outstanding life scientists from the nominees of universities and research institutions in the United States through strict selection and becomes HHMI researchers. At present, the Institute has 304 researchers in the United States, of whom 16 are Nobel Prize winners and 160 are academicians of the American Academy of Sciences.

In addition, Professor He Chuan opened the Center for Synthetic and Functional Molecular Biology in Peking University and served as its director. Professor He Chuan also initiated the "Future Science Award" and served as a member of the jury, and won the 20 17 paulo marques Cancer Research Award.

Professor He Chuan is mainly engaged in chemical biology, nucleic acid chemistry, biology and genetics. In recent years, many important discoveries have been made in methylation modification, especially on 5hmC and m6A. Up to now, 230 SCI academic papers have been published, and more than 5 research articles/kloc-0 have been published in top international journals (Nature, Science, Cell).

Because of Professor He Chuan's special chemical background, he developed the 5hmC Qualcomm detection technology to fill the technical gap in the field of epigenetic modification. At present, this technology has obtained and applied for 4 patents1at home and abroad. This year, Professor He Chuan also won the ACS lecture prize for chemical biology awarded by the American Chemical Society.